vTv Therapeutics Inc (VTVT)
27.62
-1.28
(-4.43%)
USD |
NASDAQ |
May 24, 16:00
27.62
0.00 (0.00%)
After-Hours: 17:06
vTv Therapeutics Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 4.404M |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | -0.021M |
March 31, 2022 | |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | -0.068M |
September 30, 2019 | 0.31M |
June 30, 2019 | |
March 31, 2019 |
Date | Value |
---|---|
December 31, 2018 | 0.00 |
September 30, 2018 | -0.005M |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.012M |
December 31, 2017 | -0.018M |
September 30, 2017 | 0.032M |
June 30, 2017 | 0.00 |
March 31, 2017 | -0.039M |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | -0.083M |
March 31, 2016 | 0.00 |
December 31, 2015 | -0.037M |
September 30, 2015 | -0.009M |
June 30, 2015 | -0.029M |
March 31, 2015 | -0.004M |
December 31, 2014 | 0.196M |
September 30, 2014 | -0.009M |
June 30, 2014 | -0.009M |
March 31, 2014 | -0.017M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.068M
Minimum
Dec 2019
4.404M
Maximum
Dec 2023
0.4205M
Average
--
Median
Jun 2021
Cash from Investing (Quarterly) Benchmarks
Altimmune Inc | -39.52M |
Palatin Technologies Inc | 0.00 |
Oragenics Inc | -- |
Viking Therapeutics Inc | -459.79M |
G1 Therapeutics Inc | 5.289M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -7.335M |
Cash from Financing (Quarterly) | 50.14M |
Free Cash Flow | -21.25M |
Free Cash Flow Per Share (Quarterly) | -1.771 |
Free Cash Flow to Equity (Quarterly) | -7.144M |
Free Cash Flow to Firm (Quarterly) | -7.335M |
Free Cash Flow Yield | -29.47% |